K182070 is an FDA 510(k) clearance for the BioHorizons Tapered IM Implants. Classified as Implant, Endosseous, Root-form (product code DZE), Class II - Special Controls.
Submitted by BioHorizons Implant Systems, Inc. (Birmingham, US). The FDA issued a Cleared decision on October 10, 2018 after a review of 70 days - a notably fast clearance cycle.
This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3640 - the FDA dental device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.